Drug
Minocycline
Minocycline: highest development phase Approved, developed by Lupin, Merck. 2 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Lupin, Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| MINOCYCLINE HYDROCHLORIDE | Approved | |
| Minocycline NCT01134627 | Phase 2 | Multiple Sclerosis, Relapsing-Remitting |
Latest
Follow Minocycline on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.